BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.5M data for 728K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

Advanced Search

18 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Three-dimensional quantitative structure-activity relationships from molecular similarity matrices and genetic neural networks. 2. Applications.EBI
Harvard University
Receptor surface models. 2. Application to quantitative structure-activity relationships studies.EBI
Molecular Simulations
1-(substituted-benzyl)imidazole-2(3H)-thione inhibitors of dopamine beta-hydroxylase.EBI
University of Illinois
 
Synthesis of indane derivatives as mechanism-based inhibitors of dopamine β-hydroxylaseEBI
TBA
NVP-BHG712: Effects of Regioisomers on the Affinity and Selectivity toward the EPHrin Family.EBI
Johann Wolfgang Goethe University
Soluble Guanylate Cyclase Inhibitors Discovered among Natural Compounds.EBI
Inserm U1182 - Cnrs Umr7645
Pyridine alkaloids with activity in the central nervous system.EBI
University of Auckland
The biology and synthesis of α-hydroxytropolones.EBI
City University of New York
Unsaturated heterocyclic amines as potent time-dependent inhibitors of dopamine beta-hydroxylase.EBI
TBA
Multisubstrate inhibitors of dopamine beta-hydroxylase. 2. Structure-activity relationships at the phenethylamine binding site.EBI
TBA
Multisubstrate inhibitors of dopamine beta-hydroxylase. 1. Some 1-phenyl and 1-phenyl-bridged derivatives of imidazole-2-thione.EBI
TBA
Substituted 1-benzylimidazole-2-thiols as potent and orally active inhibitors of dopamine beta-hydroxylase.EBI
TBA
Inhibitors of dopamine beta-hydroxylase. 3. Some 1-(pyridylmethyl)imidazole-2-thiones.EBI
TBA
Beta-substituted phenethylamines as high-affinity mechanism-based inhibitors of dopamine beta-hydroxylase.EBI
Smith Kline & French Laboratories
Synthesis of some novel potent and selective catechol O-methyltransferase inhibitors.EBI
Orion
Benzofurans as mechanism-based inhibitors of dopamine beta-hydroxylase.EBI
Pennsylvania State University
1-(Thienylalkyl)imidazole-2(3H)-thiones as potent competitive inhibitors of dopamine beta-hydroxylase.EBI
Merrell Dow Research Institute
Some benzyl-substituted imidazoles, triazoles, tetrazoles, pyridinethiones, and structural relatives as multisubstrate inhibitors of dopamine beta-hydroxylase. 4. Structure-activity relationships at the copper binding site.EBI
Smith Kline & French Laboratories